Markel Group’s Bristol-Myers Squibb BMY Stock Holding History

Markel Group’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-10,000	Closed	-$632K	–	139
2018 Q1	$632K	Hold	10,000	–	–	0.01%	130
2017 Q4	$613K	Hold	10,000	–	–	0.01%	132
2017 Q3	$637K	Hold	10,000	–	–	0.01%	132
2017 Q2	$557K	Hold	10,000	–	–	0.01%	130
2017 Q1	$544K	Hold	10,000	–	–	0.01%	128
2016 Q4	$584K	Hold	10,000	–	–	0.01%	128
2016 Q3	$539K	Hold	10,000	–	–	0.01%	122
2016 Q2	$735K	Hold	10,000	–	–	0.02%	123
2016 Q1	$639K	Hold	10,000	–	–	0.02%	126
2015 Q4	$688K	Buy	+10,000	New	+$661K	0.02%	121

Other funds holding BMY

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Markel Group's BMY Position: Q2 2018 in Review

Markel Group sold out of Bristol-Myers Squibb (BMY) in Q2 2018, closing a stake of 10,000 shares — an estimated $632K sold.

Markel Group first reported a position in BMY in Q4 2015 and held it in 10 quarters. The position peaked at $735K in Q2 2016. 1,691 funds tracked by Wall St. Rank hold BMY as of Q2 2018.

Markel Group reported no remaining Bristol-Myers Squibb position as of Q2 2018 after selling out during the quarter.
Markel Group sold 10,000 Bristol-Myers Squibb shares in Q2 2018, an estimated $632K.
Markel Group first reported a position in Bristol-Myers Squibb in Q4 2015 and held it in 10 quarters.
Markel Group's Bristol-Myers Squibb position peaked at $735K in Q2 2016.
1,691 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2018.

Based on Markel Group's 13F filing for Q2 2018, filed 3 Aug 2018.